Fondo Bibliografico Internacional Octubre 2003
Trasplante hepático
Renal function improves in liver transplantation recipients
when switched from a calcineurin inhibitor to sirolimus. Fairbanks KD, Eustace
JA, Fine D, Thuluvath PJ. Liver Transplantation 2003;9:1079-85.
La monoterapia con rapamicina produce una
buena inmunosupresión y pocos efectos adversos.
MELD and the practicing gastroenterologist. Brown RS Jr, Brenner
DA. Gastroenterology 2003;125:1009.
Editorial.
Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion
injury. Jaeschke H, Lemasters JJ. Gastroenterology 2003;125:1246-57.
Revisión sobre los mecanismos de apoptosis
y necrosis en el daño isquemia reperfusión en el trasplante
hepático.
High frequency of chimerism in transplanted livers. Ng IO,
Chan KL, Shek WH, et al. Hepatology 2003;38:989-98.
Quimerismo en el trasplante hepático.
Extracorporeal liver support based on primary human liver
cells and albumin dialysis - treatment of a patient with primary graft non-function.
Sauer IM, Zeilinger K, Pless G, Kardassis D, Theruvath T, Pascher A, Goetz
M, Neuhaus P, Gerlach JC. Journal of Hepatology 2003;39:649-53.
Caso clínico.
Human leukocyte antigen-G (HLA-G) expression in biliary epithelial
cells is associated with allograft acceptance in liver-kidney transplantation.
Creput C, Durrbach A, Menier C, Guettier C, Samuel D, Dausset J, Charpentier
B, Carosella ED, Rouas-Freiss N. Journal of Hepatology 2003;39:587-594.
La expresión de este antígeno en las
células del epitelio biliar se asocia con ausencia de rechazo crónico
del hígado trasplantado.
Future of adult living donor liver transplantation. RM, Busuttil
RW. Liver Transplantation 2003;9(10 Suppl):S73-9.
Revisión.
Regulation and oversight of adult living donor liver transplantation.
Miller CM. Liver Transplantation 2003;9(10 Suppl):S69-72.
Revisión.
Role of adult living donor liver transplantation in patients
with hepatitis C. Everson GT, Trotter J. Liver Transplantation 2003;9(10 Suppl):S64-8.
Revisión.
Role of adult living liver donation in patients with hepatocellular
cancer. Roberts JP. Liver Transplantation 2003;9(10 Suppl):S60-3.
Revisión.
Early and late complications in the recipient of an adult
living donor liver. Broelsch CE, Frilling A, Testa G, Cicinnati V, Nadalin
S, Paul A, Malago M. Liver Transplantation 2003;9(10 Suppl):S50-3.
Revisión.
Early and late complications in the right-lobe adult living
donor. Pomfret EA. Liver Transplantation 2003;9(10 Suppl):S45-9.
Revisión.
Donor and recipient outcomes after adult living donor liver
transplantation. Humar A. Liver Transplantation 2003;9(10 Suppl):S42-4.
Revisión.
Hepatic regeneration in living donor liver transplantation.
Olthoff KM. Liver Transplantation 2003;9(10 Suppl):S35-41.
Revisión.
Surgical techniques used in adult living donor liver transplantation.
Belghiti J, Kianmanesh R. Liver Transplantation 2003;9(10 Suppl):S29-34.
Revisión.
Evaluation of the donor liver for living donor liver transplantation.
Brandhagen D, Fidler J, Rosen C. Liver Transplantation 2003;9(10 Suppl):S16-28.
Revisión.
Psychosocial assessment of adult living liver donors. Shrestha
R. Liver Transplantation 2003;9(10 Suppl):S8-S11.
Revisión.
Selection of donors for living donor liver transplantation.
Trotter JF. Liver Transplantation 2003;9(10 Suppl):S2-7.
Revisión.
Pharmacogenomics in liver Transplantation. McAlister V. Liver
Transplantation 2003;9(10):1114-5.
Editorial.
Death from donor-transmitted malignancy despite emergency
liver retransplantation. Lipshutz GS, Baxter-Lowe LA, Nguyen T, Jones KD,
Ascher NL, Feng S. Liver Transplantation 2003;9(10):1102-7.
Caso clínico.
Making hepatocytes from stem cells: Where are we? Dahlke
MH, Schlitt HJ. Liver Transplantation 2003;9(10):1100-1.
Editorial.
